Literature DB >> 30599229

Emerging vistas in theranostic medicine.

Yashna Shetty1, Priyanka Prabhu1, Bala Prabhakar1.   

Abstract

Recent years have witnessed a paradigm shift in the focus of healthcare towards development of customized therapies which cater to the unmet needs in a myriad of disease areas such as cancer, infections, cardiovascular diseases, neurodegenerative disorders and inflammatory disorders. The term 'theranostic' refers to such multifunctional systems which combine the features of diagnosis and treatment in a single platform for superior control of the disease. Theranostic systems enable detection of disease, treatment and real time monitoring of the diseased tissue. Theranostic nanocarriers endowed with multiple features of imaging, targeting, and providing on-demand delivery of therapeutic agents have been designed for enhancement of therapeutic outcomes. Fabrication of theranostics involves utilization of materials having distinct properties for imaging, targeting, and programming drug release spatially and temporally. Although the field of theranostics has been widely researched and explored so far for treatment of different types of cancer, there have been considerable efforts in the past few years to extend its scope to other areas such as infections, neurodegenerative disorders and cardiovascular diseases. This review showcases the potential applications of theranostics in disease areas other than cancer. It also highlights the cardinal issues which need to be addressed for successful clinical translation of these theranostic tools.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Infection; Inflammation; Nanocarrier; Neurodegenerative disorder; Theranostics

Mesh:

Year:  2018        PMID: 30599229     DOI: 10.1016/j.ijpharm.2018.12.068

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

Review 1.  Human microbiome and prostate cancer development: current insights into the prevention and treatment.

Authors:  Solmaz Ohadian Moghadam; Seyed Ali Momeni
Journal:  Front Med       Date:  2020-06-30       Impact factor: 4.592

Review 2.  Nanovectorization of Prostate Cancer Treatment Strategies: A New Approach to Improved Outcomes.

Authors:  Kenneth Omabe; Clément Paris; François Lannes; David Taïeb; Palma Rocchi
Journal:  Pharmaceutics       Date:  2021-04-21       Impact factor: 6.321

Review 3.  Applications of Nanomaterials in Leishmaniasis: A Focus on Recent Advances and Challenges.

Authors:  Kiran Saleem; Zainab Khursheed; Christophe Hano; Iram Anjum; Sumaira Anjum
Journal:  Nanomaterials (Basel)       Date:  2019-12-09       Impact factor: 5.076

Review 4.  Nanotheranostics: A Possible Solution for Drug-Resistant Staphylococcus aureus and their Biofilms?

Authors:  Dina A Mosselhy; Mhd Assad; Tarja Sironen; Mady Elbahri
Journal:  Nanomaterials (Basel)       Date:  2021-01-02       Impact factor: 5.076

5.  Radioiodination of Modified Porous Silica Nanoparticles as a Potential Candidate of Iodine-131 Drugs Vehicle.

Authors:  Maria Christina Prihatiningsih; Teguh Ariyanto; Edy Giri Rachman Putra; Veronika Yulianti Susilo; Isa Mahendra; Imam Prasetyo
Journal:  ACS Omega       Date:  2022-04-18

6.  A simple cost-effective microfluidic platform for rapid synthesis of diverse metal nanoparticles: A novel approach towards fighting SARS-CoV-2.

Authors:  Amit Prabhakar; Ishita Bansal; Ankur Jaiswar; Nimisha Roy; Deepti Verma
Journal:  Mater Today Proc       Date:  2021-06-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.